Russian cancer vaccine: Russia has reported that its cancer vaccine

Russia has reported that its cancer vaccine "Enteromix" has completed preclinical trials—demonstrating both safety and high efficacy. Veronika Skvortsova, head of the Russian Federal Medical ... Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis Russia's Enteromix, a personalized mRNA-based cancer vaccine, has demonstrated 100% efficacy and safety in clinical trials, offering a potential breakthrough in cancer treatment. Developed using ... Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis